Detection of Human Papillomavirus in Cervical Lymph Nodes: A Highly Effective Strategy for Localizing Site of Tumor Origin

Clinical Cancer Research

Volumn 9, Issue 17, 2003, Pages 6469-6475

  Begum, Shahnaz ^a   Gillison, Maura L ^a   Ansari Lari, M Ali ^a   Shah, Keerti ^a   Westra, William H ^a,b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P16;

ARTICLE; CANCER DIAGNOSIS; CERVICAL LYMPH NODE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; GENE OVEREXPRESSION; HEAD AND NECK CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NONHUMAN; OROPHARYNX CANCER; PRIORITY JOURNAL; RELIABILITY; RETINOBLASTOMA; TUMOR LOCALIZATION; VIRUS DETECTION; WART VIRUS;

CARCINOMA, SQUAMOUS CELL; CERVIX UTERI; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM METASTASIS; PAPILLOMAVIRIDAE;

EID: 0348223935     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Greenlee, R. T., Hill-Harmon, M. B., Murray, T., and Thun, M. Cancer statistics, 2001. Ca-Cancer J. Clin., 51: 15-36, 2001.
2. Kim, E. S., Kies, M., and Herbst, R. S. Novel therapeutics for head and neck cancer. Curr. Opin. Oncol., 14: 334-342, 2002.
3. Sessions, R. B. and Picken C. A. Malignant cervical adenopathy. In: C. W. Cummings, J. M. Fredrickson, L. A. Harker, C. J. Krause, M. A. Richardson, and D. E. Schuller (eds.), Otolaryngology-Head and Neck Surgery, 3rd ed, pp. 1737-1757. New York: Mosby, 1998.
4. Martin, H. R. C. The diagnostic significance of a lump in the neck. Postgrad. Med., 11: 491-500, 1952.
5. de Braud, F., and al Sarraf, M. Diagnosis and management of squamous cell carcinoma of unknown primary tumor site of the neck. Semin. Oncol., 20: 273-278, 1993.
6. Gillison, M. L., Koch, W. M., Capone, R. B., Spafford, M., Westra, W. H., Wu, L., Zahurak, M. L., Daniel, R. W., Viglione, M., Symer, D. E., Shah, K. V., and Sidransky, D. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J. Natl. Cancer Inst., 92: 709-720, 2000.
7. Helbig, M., Andl, T., Kahn, T., Klein-Kuhne, W., Conradt, C., Dietz, A., and Bosch, F. X. The role of oncogenic human papillomaviruses in tonsillar squamous cell carcinomas with functional inactivation of the retinoblastoma protein. HNO, 47: 796-803, 1999.
8. Paz, I. B., Cook, N., Odom-Maryon, T., Xie, Y., and Wilczynski, S. P. Human papillomavirus (HPV) in head and neck cancer. An association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring. Cancer (Phila.), 79: 595-604, 1997.
9. Andl, T., Kahn, T., Pfuhl, A., Nicola, T., Erber, R., Conradt, C., Klein, W., Helbig, M., Dietz, A., Weidauer, H., and Bosch, F. X. Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. Cancer Res., 58: 5-13, 1998.
10. Wiest, T., Schwarz, E., Enders, C., Flechtenmacher, C., and Bosch, F. X. Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control. Oncogene, 21: 1510-1517, 2002.
11. van Houten, V. M. M., Snijders, P. J. F., van den Brekel, M. W. M., Kummer, J. A., Meijer, C. J. L. M., van Leeuwen, B., Denkers, F., Smeele, L. E., Snow, G. B., and Brakenhoff, R. H. Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas. Int. J. Cancer, 93: 232-235, 2001.
12. Khleif, S. N., DeGregori, J., Yee, C. L., Otterson, G. A., Kaye, F. J., Nevins, J. R., and Howley, P. M. Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity. Proc. Natl. Acad. Sci. USA, 93: 4350-4354, 1996.
13. Serrano, M., Hannon, G. J., and Beach, D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (Lond.), 366: 704-707, 1993.
14. Negri, G., Egarter-Vigl, E., Kasal, A., Romano, F., Haitel, A., and Mian, C. p16INK4a Is a useful marker for the diagnosis of adenocarcinoma of the cervix uteri and its precursors: an immunohistochemical study with immunocytochemical correlations. Am. J. Surg. Pathol., 27: 187-193, 2003.
15. Klaes, R., Friedrich, T., Spitkovsky, D., Ridder, R., Rudy, W., Petry, U., Dallenbach-Hellweg, G., Schmidt, D., and von Knebel, D. M. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int. J. Cancer, 92: 276-284, 2001.
16. Sano, T., Oyama, T., Kashiwabara, K., Fukuda, T., and Nakajima, T. Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am. J. Pathol., 153: 1741-1748, 1998.
17. Kerstens, H. M., Poddighe, P. J., and Hanselaar, A. G. A novel in situ hybridization signal amplification method based on the deposition of biotinylated tyramine. J. Histochem. Cytochem., 43: 347-352, 1995.
18. Huang, C. C., Qiu, J. T., Kashima, M. L., Kurman, R. J., and Wu, T. C. Generation of type-specific probes for the detection of single-copy human papillomavirus by a novel in situ hybridization method. Mod. Pathol., 11: 971-977, 1998.
19. Gravitt, P. E., Peyton, C. L., Apple, R. J., and Wheeler, C. M. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J. Clin. Microbiol., 36: 3020-3027, 1998.
20. Peyton, C. L., Gravitt, P. E., Hunt, W. C., Hundley, R. S., Zhao, M. F., Apple, R. J., and Wheeler, C. M. Determinants of genital human papillomavirus detection in a US population. J. Infect. Dis., 183: 1554-1564, 2001.
21. Samama, B., Plas-Roser, S., Schaeffer, C., Chateau, D., Fabre, M., and Boehm, N. HPV DNA detection by in situ hybridization with catalyzed signal amplification on thin-layer cervical smears. J. Histochem. Cytochem., 50: 1417-1420, 2002.
22. Califano, J., Westra, W. H., Koch, W., Meininger, G., Reed, A., Yip, L., Boyle, J. O., Lonardo, F., and Sidransky, D. Unknown primary head and neck squamous cell carcinoma: molecular identification of the site of origin. J. Natl. Cancer Inst., 91: 599-604, 1999.
23. Nakao, K., Yuge, T., Mochiki, M., Nibu, K., and Sugasawa, M. Detection of epstein-barr virus in metastatic lymph nodes of patients with nasopharyngeal carcinoma and a primary unknown carcinoma. Arch. Otolaryngol. Head Neck Surg., 129: 338-340, 2003.
24. Feinmesser, R., Miyazaki, I., Cheung, R., Freeman, J. L., Noyek, A. M., and Dosch, H. M. Diagnosis of nasopharyngeal carcinoma by DNA amplification of tissue obtained by fine-needle aspiration. N. Engl. J. Med., 326: 17-21, 1992.
25. Chan, M. K., Huang, D. W., Ho, Y. H., and Lee, J. C. Detection of Epstein-Barr virus-associated antigen in fine needle aspiration smears from cervical lymph nodes in the diagnosis of nasopharyngeal carcinoma. Acta Cytol., 33: 351-354, 1989.
26. Macdonald, M. R., Freeman, J. L., Hui, M. F., Cheung, R. K., Warde, P., McIvor, N. P., Irish, J., and Dosch, H. M. Role of Epstein-Barr virus in fine-needle aspirates of metastatic neck nodes in the diagnosis of nasopharyngeal carcinoma. Head Neck. 17: 487-493, 1995.
27. Lee, W. Y., Hsiao, J. R., Jin, Y. T., and Tsai, S. T. Epstein-Barr virus detection in neck metastases by in-situ hybridization in fine-needle aspiration cytologic studies: an aid for differentiating the primary site. Head Neck, 22: 336-340, 2000.
28. Klussmann, J. P., Weissenborn, S. J., Wieland, U., Dries, V., Kolligs, J., Jungehuelsing, M., Eckel, H. E., Dienes, H. P., Pfister, H. J., and Fuchs, P. G. Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas. Cancer (Phila.), 92: 2875-2884, 2001.
29. Mellin, H., Dahlgren, L., Munck-Wikland, E., Lindholm, J., Rabbani, H., Kalantari, M., and Dalianis, T. Human papillomavirus type 16 is episomal and a high viral load may be correlated to better prognosis in tonsillar cancer. Int. J. Cancer. 102: 152-158, 2002.
30. Mork, J., Lie, A. K., Glattre, E., Hallmans, G., Jellum, E., Koskela, P., Moller, B., Pukkala, E., Schiller, J. T., Youngman, L., Lehtinen, M., and Dillner, J. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N. Engl. J. Med., 344: 1125-1131, 2001.
31. Wilczynski, S. P., Lin, B. T., Xie, Y., and Paz, I. B. Detection of human papillomavirus DNA and oncoprotein overexpression are associated with distinct morphological patterns of tonsillar squamous cell carcinoma. Am. J. Pathol., 152: 145-156, 1998.
32. Reed, A. L., Califano, J., Cairns, P., Westra, W. H., Jones, R. M., Koch, W., Ahrendt, S. A., Eby, Y., Sewell, D., Nawroz, H., Bartek, J., and Sidransky, D. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res., 56: 3630-3633, 1994.
33. Klussmann, J. P., Gultekin, E., Weissenborn, S. J., Wieland, U., Dries, V., Dienes, H. P., Eckel, H. E., Pfister, H. J., and Fuchs, P. G. Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. Am. J. Pathol., 162: 747-753, 2003.
34. McNeil, C. HPV in oropharyngeal cancers: new data inspire hope for vaccines. J. Natl. Cancer Inst., 92: 680-681, 2000.
35. Murphy, N., Ring, M., Killalea, A. G., Uhlmann, V., O'Donovan, M., Mulcahy, F., Turner, M., McGuinness, E., Griffin, M., Martin, C., Sheils, O., and O'Leary, J. J. p16(INK4A) as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep (TM) smears. J. Clin. Pathol., 56: 56-63, 2003.
36. Vocaturo, A., Marandino, F., Celata, E., Caffo, A., Moauro, M., Vocaturo, G., and Donnorso, R. P. Colourimetric signal amplification of in situ hybridization assay for human papillomavirus DNA detection in cytological samples. J. Exp. Clin. Cancer Res., 21: 239-246, 2002.